Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Gastric Cancer

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    March 2025

  1. Pathological response guides adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in surgically resected gastro-oesophageal cancer (SPACE-FLOT): international cohort study.
    Br J Surg. 2025;112:znaf056.
    PubMed     Abstract available


  2. VAN HOOTEGEM SJM, van der Linde M, Schneider MA, Kim J, et al
    Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre study.
    Br J Surg. 2025;112:znaf043.
    PubMed     Abstract available


    November 2024
  3. BYRNE BE, Siaw-Acheampong K, Evans O, Taylor J, et al
    REsolution of Symptoms afTer Oesophago-gastric cancer REsection delphi (RESTOREd)-standardizing the definition, investigation and management of gastrointestinal symptoms and conditions after surgery.
    Br J Surg. 2024;111:znae286.
    PubMed     Abstract available


    October 2024
  4. WALKER RC, Barman S, Pucher PH, Singh P, et al
    Association of Upper Gastrointestinal Surgery of Great Britain and Ireland (AUGIS)/perioperative quality initiative (POQI) consensus statement on prehabilitation in oesophagogastric surgery.
    Br J Surg. 2024;111:znae223.
    PubMed     Abstract available


    July 2024
  5. BRANDL A, van Sandick JW
    Treatment of gastric cancer peritoneal metastases: role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Br J Surg. 2024;111:znae149.
    PubMed    


  6. XIE D, Shen J, Gong J
    Author response to: Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
    Br J Surg. 2024;111:znae157.
    PubMed    


  7. LIANG X, Wu J, Yu H
    Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
    Br J Surg. 2024;111:znae156.
    PubMed    


  8. BROWN LR, Crumley AB, Skipworth RJE
    Author response to: Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae173.
    PubMed    


  9. ARKLE TS, Sivarajan SG, Penney NC, Rafiee H, et al
    Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae172.
    PubMed    


    June 2024
  10. ZHANG W, Huang J
    Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
    Br J Surg. 2024;111:znae145.
    PubMed    


  11. XIE D, Shen J, Gong J
    Author response to: Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
    Br J Surg. 2024;111:znae146.
    PubMed    


    May 2024
  12. ZAFFARONI G, Mannucci A, Koskenvuo L, de Lacy B, et al
    Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EH
    Br J Surg. 2024;111:znae070.
    PubMed     Abstract available


  13. GUCHELAAR NAD, Nasserinejad K, Mostert B, Koolen SLW, et al
    Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis.
    Br J Surg. 2024;111:znae116.
    PubMed     Abstract available


  14. XIE D, Shen J, Liu L, Cao B, et al
    Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
    Br J Surg. 2024;111:znae106.
    PubMed     Abstract available


  15. LI K, Leng X, Han Y, Peng L, et al
    Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae136.
    PubMed    


  16. BROWN LR, Crumley AB, Skipworth RJE
    Author response to: Comment on: Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae135.
    PubMed    


    April 2024
  17. BROWN LR, Thomson GG, Gardner E, Chien S, et al
    Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae098.
    PubMed     Abstract available


  18. SCHNEIDER MA, Gutschow CA
    Author response to: Comment on: Defining benchmarks for total and distal gastrectomy: global multicentre analysis.
    Br J Surg. 2024;111:znae079.
    PubMed    


    January 2024
  19. LIU W, Chen X, Zhou Z, Chen Y, et al
    Reinforcement of the stapled duodenal stump during laparoscopic gastrectomy.
    Br J Surg. 2024;111:znad305.
    PubMed    



  20. Erratum to: Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znae025.
    PubMed    


  21. SCHNEIDER MA, Kim J, Berlth F, Sugita Y, et al
    Defining benchmarks for total and distal gastrectomy: global multicentre analysis.
    Br J Surg. 2024;111:znad379.
    PubMed    


  22. LI ZY, Wei B, Zhou YB, Li TY, et al
    Long-term oncological outcomes of robotic versus laparoscopic gastrectomy for gastric cancer: multicentre cohort study.
    Br J Surg. 2024;111:znad435.
    PubMed     Abstract available


    September 2023
  23. BAUSYS A, Luksta M, Anglickiene G, Maneikiene VV, et al
    Effect of home-based prehabilitation on postoperative complications after surgery for gastric cancer: randomized clinical trial.
    Br J Surg. 2023 Sep 26:znad312. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  24. MARKAR SR, Guazzelli A, Taylor A, Jones LL, et al
    Protocol for open-label randomized clinical trial of intensive surveillance versus standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer.
    Br J Surg. 2023 Jun 28:znad180. doi: 10.1093.
    PubMed    


  25. VAN DIEREN JM, van der Post RS, Bisseling TM
    Shifting perceptions on endoscopic surveillance and timing of prophylactic gastrectomy for hereditary diffuse gastric cancer.
    Br J Surg. 2023 Jun 24:znad192. doi: 10.1093.
    PubMed    


    March 2023
  26. BAXTER MA, Khan KS, Gall LS, Samuelson C, et al
    Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study.
    Br J Surg. 2023;110:456-461.
    PubMed     Abstract available


  27. PUCHER PH, Park MH, Cromwell DA, Crosby TC, et al
    Diagnosis and treatment for gastro-oesophageal cancer in England and Wales: analysis of the National Oesophago-Gastric Cancer Audit (NOGCA) database 2012-2020.
    Br J Surg. 2023 Mar 27:znad065. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.